Page Image

The Uromigos

The Uromigos, Thomas Powles, MD, and Brian Rini, MD, FASCO, highlight the latest developments in genitourinary cancers. Each podcast episode features a guest expert from around the world discussing the latest data, debates, and manuscripts relevant to the practical clinical care of GU oncology patients.


Latest Episode

Episode 262: Paper of the Month - Abiraterone +/- Cabazitaxel in CRPC
Susan F. Slovin, MD, PhD, discusses her recent paper that examined abiraterone with and without cabazitaxel for mCRPC to determine if the combination is effective in castration-resistant patients. Dr. Slovin is an attending physician at the Sidney Kimmel Center for Prostate and Urologic Cancers ...

The Uromigos: Live & Unplugged 2022

Kidney Cancer Discussions

Dr. Brian Rini’s Disclosures

Research Funding to Institution: Pfizer, Hoffman-LaRoche, Incyte, AstraZeneca, Taris, Seattle Genetics, Arrowhead Pharmaceuticals, Immunomedics, BMS, Mirati Therapeutics, Merck, Surface Oncology, Dragonfly Therapeutics, Aravive, Exelixis

Consulting: BMS, Pfizer, GNE/Roche, Aveo, Synthorx, Compugen, Merck, Corvus, Surface Oncology, 3DMedicines, Aravive, Alkermes, Arrowhead, GSK, Shionogi, Eisai

Stock: PTC therapeutics